NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.05% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 0.95% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 0.91% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 0.84% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 0.83% |
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 0.82% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 0.81% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 0.80% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 0.76% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 0.76% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 0.75% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 0.75% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 0.74% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.74% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 0.74% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 0.70% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 0.70% |